Indiva Finalizes White-Label Licensing and Manufacturing Agreement With Dycar Pharmaceuticals Ltd. and Grants Options
LONDON, Ontario, Feb. 18, 2020 (GLOBE NEWSWIRE) — Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF) is pleased to announce that further to its press release dated December 11,...